Copyright
©The Author(s) 2025.
World J Meta-Anal. Jun 18, 2025; 13(2): 107171
Published online Jun 18, 2025. doi: 10.13105/wjma.v13.i2.107171
Published online Jun 18, 2025. doi: 10.13105/wjma.v13.i2.107171
Table 1 Study characteristics
| Ref. | Design | Country | Age (Intervention/Control) | % Male (Intervention/Control) | Intervention/Placebo | Median follow up interval |
| Straumann et al[13], 2011 | RCT | Switzerland | 38.0 ± 11.7/34 ± 13.9 | 92.86/78.57 | 14/14 | 50 weeks |
| Straumann et al[14], 2020 | RCT | Switzerland | 36.5 ± 10.97/36 ± 9.9 | 83.8/80.9 | 136/68 | 48 weeks |
| Schupack et al[16], 2021 | Retrospective | United States | 45 ± 14.2/36.5 ± 11.0 | 50.0/66.7 | 14/9 | 3 years |
| Dellon et al[15], 2022 | RCT | United States | 36.8 ± 14.1/36.1 ± 11.7 | 56.0/69.6 | 25/23 | 36 weeks |
- Citation: Wu YZ, Kudlak M, Garza M, Grieme A, Liu KS, Kwon JJ, Smith ER, Yatsynovich E, Bushe B. Swallowed topical steroid maintenance therapy for eosinophilic esophagitis: A systematic review and meta-analysis. World J Meta-Anal 2025; 13(2): 107171
- URL: https://www.wjgnet.com/2308-3840/full/v13/i2/107171.htm
- DOI: https://dx.doi.org/10.13105/wjma.v13.i2.107171